Variant report

Variant	esv3424039
Chromosome Location	chr6:29439297-29504564
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:345)
CpG islands
(count:1831)
Chromatin interactive
region (count:26)
LncRNA
region (count:20)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:345 , 50 per page) page: 1 2 3 4 5 6 7

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr6:29459520-29459683	K562	blood:	n/a	n/a
2	ATF1	chr6:29459294-29459754	K562	blood:	n/a	n/a
3	ATF1	chr6:29458475-29458935	K562	blood:	n/a	n/a
4	ATF1	chr6:29484009-29484209	K562	blood:	n/a	n/a
5	ATF1	chr6:29465238-29465245	K562	blood:	n/a	n/a
6	BACH1	chr6:29455457-29455787	K562	blood:	n/a	n/a
7	BHLHE40	chr6:29478030-29478400	K562	blood:	n/a	n/a
8	BHLHE40	chr6:29458370-29458968	K562	blood:	n/a	n/a
9	BHLHE40	chr6:29478160-29478319	HepG2	liver:	n/a	n/a
10	BHLHE40	chr6:29467541-29467772	K562	blood:	n/a	n/a
11	BHLHE40	chr6:29445624-29445942	K562	blood:	n/a	n/a
12	BHLHE40	chr6:29477112-29477348	GM12878	blood:	n/a	n/a
13	BHLHE40	chr6:29459289-29459713	K562	blood:	n/a	n/a
14	BRCA1	chr6:29476984-29477087	GM12878	blood:	n/a	n/a
15	CBX3	chr6:29483750-29484388	HCT-116	colon:	n/a	n/a
16	CBX3	chr6:29483797-29484274	HCT-116	colon:	n/a	n/a
17	CCNT2	chr6:29458160-29458786	K562	blood:	n/a	n/a
18	CEBPB	chr6:29451556-29451893	HepG2	liver:	n/a	chr6:29451728-29451739
19	CEBPB	chr6:29490658-29490690	K562	blood:	n/a	n/a
20	CEBPB	chr6:29468924-29469249	K562	blood:	n/a	chr6:29469074-29469087 chr6:29469076-29469085 chr6:29469074-29469085 chr6:29469075-29469086
21	CEBPB	chr6:29470090-29470222	HepG2	liver:	n/a	n/a
22	CEBPB	chr6:29446581-29446887	ECC-1	luminal epithelium:	n/a	chr6:29446683-29446694
23	CEBPB	chr6:29451605-29451865	MCF-7	breast:	n/a	chr6:29451728-29451739
24	CEBPB	chr6:29461058-29461389	HepG2	liver:	n/a	chr6:29461222-29461233
25	CEBPB	chr6:29468894-29469267	HepG2	liver:	n/a	chr6:29469074-29469087 chr6:29469076-29469085 chr6:29469074-29469085 chr6:29469075-29469086
26	CEBPB	chr6:29468890-29469252	MCF-7	breast:	n/a	chr6:29469074-29469087 chr6:29469076-29469085 chr6:29469074-29469085 chr6:29469075-29469086
27	CEBPB	chr6:29461104-29461374	IMR90	lung:	n/a	chr6:29461222-29461233
28	CEBPB	chr6:29446548-29446769	K562	blood:	n/a	chr6:29446683-29446694
29	CEBPB	chr6:29461156-29461405	MCF-7	breast:	n/a	chr6:29461222-29461233
30	CEBPB	chr6:29446488-29446990	A549	lung:	n/a	chr6:29446683-29446694
31	CEBPB	chr6:29461061-29461396	K562	blood:	n/a	chr6:29461222-29461233
32	CEBPB	chr6:29492851-29493397	H1-hESC	embryonic stem cell:	n/a	chr6:29493216-29493227
33	CEBPB	chr6:29493070-29493404	HepG2	liver:	n/a	chr6:29493216-29493227
34	CEBPB	chr6:29446448-29447033	K562	blood:	n/a	chr6:29446683-29446694
35	CEBPB	chr6:29461057-29461393	H1-hESC	embryonic stem cell:	n/a	chr6:29461222-29461233
36	CEBPB	chr6:29446483-29446932	K562	blood:	n/a	chr6:29446683-29446694
37	CEBPB	chr6:29446494-29446887	A549	lung:	n/a	chr6:29446683-29446694
38	CEBPB	chr6:29446497-29446878	H1-hESC	embryonic stem cell:	n/a	chr6:29446683-29446694
39	CEBPB	chr6:29446497-29446881	HepG2	liver:	n/a	chr6:29446683-29446694
40	CEBPB	chr6:29458273-29458675	K562	blood:	n/a	n/a
41	CEBPB	chr6:29458480-29458729	K562	blood:	n/a	n/a
42	CEBPB	chr6:29493083-29493346	A549	lung:	n/a	chr6:29493216-29493227
43	CEBPB	chr6:29468925-29469256	IMR90	lung:	n/a	chr6:29469074-29469087 chr6:29469076-29469085 chr6:29469074-29469085 chr6:29469075-29469086
44	CEBPB	chr6:29446554-29446877	A549	lung:	n/a	chr6:29446683-29446694
45	CEBPB	chr6:29461154-29461365	Hela-S3	cervix:	n/a	chr6:29461222-29461233
46	CEBPB	chr6:29446613-29446744	HepG2	liver:	n/a	chr6:29446683-29446694
47	CEBPB	chr6:29446459-29446920	MCF-7	breast:	n/a	chr6:29446683-29446694
48	CEBPB	chr6:29492820-29493375	K562	blood:	n/a	chr6:29493216-29493227
49	CEBPB	chr6:29461146-29461284	K562	blood:	n/a	chr6:29461222-29461233
50	CEBPB	chr6:29446443-29446969	MCF-7	breast:	n/a	chr6:29446683-29446694

(count:1831 , 50 per page) page: 1 2 3 4 5 6 7 ... 37

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:29455365-29455415	SKMC	muscle:	n/a
2	chr6:29455365-29455415	SKMC	muscle:	n/a
3	chr6:29443446-29443496	PFSK-1	brain:	n/a
4	chr6:29457282-29457332	SKMC	muscle:	n/a
5	chr6:29454557-29454607	AG09319	gingival:	n/a
6	chr6:29455512-29455562	NH-A	brain:	n/a
7	chr6:29456611-29456661	NH-A	brain:	n/a
8	chr6:29455302-29455352	RPTEC	kidney:	n/a
9	chr6:29443446-29443496	SK-N-SH_RA	brain:	n/a
10	chr6:29442830-29442880	HCPEpiC	choroid plexus:	n/a
11	chr6:29461269-29461319	A549	lung:	n/a
12	chr6:29455126-29455176	CMK	blood:	n/a
13	chr6:29456162-29456212	HRCEpiC	kidney:	n/a
14	chr6:29456563-29456613	HEK293	kidney:	embryo
15	chr6:29454623-29454673	HMEC	breast:	n/a
16	chr6:29454888-29454938	HIPEpiC	eye:	n/a
17	chr6:29455331-29455381	CMK	blood:	n/a
18	chr6:29496514-29496564	AG09309	skin:	n/a
19	chr6:29456577-29456627	HCM	heart:	n/a
20	chr6:29456577-29456627	HPAEpiC	pulmonary alveolar:	n/a
21	chr6:29442830-29442880	HCF	heart:	n/a
22	chr6:29456577-29456627	Jurkat	blood:	n/a
23	chr6:29456577-29456627	IMR90	lung:	fetal
24	chr6:29454672-29454722	IMR90	lung:	fetal
25	chr6:29461549-29461599	HPAEpiC	pulmonary alveolar:	n/a
26	chr6:29495773-29495823	AG10803	skin:	n/a
27	chr6:29454954-29455004	HRPEpiC	eye:	n/a
28	chr6:29461269-29461319	HMEC	breast:	n/a
29	chr6:29455532-29455582	HRCEpiC	kidney:	n/a
30	chr6:29455322-29455372	NT2-D1	testis:	n/a
31	chr6:29456577-29456627	SK-N-MC	brain:	n/a
32	chr6:29457094-29457144	HRCEpiC	kidney:	n/a
33	chr6:29454755-29454805	Hepatocyte	liver:	n/a
34	chr6:29454755-29454805	PrEC	prostate:	n/a
35	chr6:29443400-29443450	HepG2	liver:	n/a
36	chr6:29455322-29455372	NHBE	bronchial:	n/a
37	chr6:29456611-29456661	SK-N-SH	brain:	n/a
38	chr6:29443400-29443450	SK-N-SH_RA	brain:	n/a
39	chr6:29454954-29455004	PrEC	prostate:	n/a
40	chr6:29443446-29443496	NHBE	bronchial:	n/a
41	chr6:29443400-29443450	Caco-2	colon:	n/a
42	chr6:29454888-29454938	ovcar-3	ovarian:	n/a
43	chr6:29454888-29454938	HepG2	liver:	n/a
44	chr6:29455126-29455176	GM19239	blood:	n/a
45	chr6:29455302-29455352	HAEpiC	amniotic membrane:	n/a
46	chr6:29455512-29455562	AG09319	gingival:	n/a
47	chr6:29495773-29495823	HAEpiC	amniotic membrane:	n/a
48	chr6:29455365-29455415	NB4	blood:	n/a
49	chr6:29455532-29455582	PFSK-1	brain:	n/a
50	chr6:29455365-29455415	GM12878	blood:	n/a

(count:26 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:29477552..29479306-chr6:29484098..29486256,2	K562	blood:
2	chr6:29457898..29460263-chr6:29462415..29464583,2	K562	blood:
3	chr6:29457898..29460263-chr6:29462415..29464583,2	K562	blood:
4	chr6:29470497..29473606-chr6:29476660..29479341,3	K562	blood:
5	chr6:29490586..29492205-chr6:29493882..29496471,2	K562	blood:
6	chr6:29484816..29486671-chr6:29489047..29491131,2	K562	blood:
7	chr6:29434261..29435839-chr6:29452792..29455620,2	K562	blood:
8	chr6:29460358..29463035-chr6:29483811..29485363,2	K562	blood:
9	chr6:29232193..29235031-chr6:29499075..29500659,2	K562	blood:
10	chr6:29494254..29496248-chr6:29505741..29508107,2	K562	blood:
11	chr6:29460358..29463035-chr6:29483811..29485363,2	K562	blood:
12	chr6:29430057..29432693-chr6:29447492..29449143,2	K562	blood:
13	chr6:29454260..29456802-chr6:29460764..29462349,2	K562	blood:
14	chr6:29484816..29486671-chr6:29489047..29491131,2	K562	blood:
15	chr6:29470497..29473606-chr6:29476660..29479341,3	K562	blood:
16	chr6:29394189..29395109-chr6:29478134..29478678,2	MCF-7	breast:
17	chr6:29469820..29472263-chr6:29475289..29476878,2	MCF-7	breast:
18	chr6:29477552..29479306-chr6:29484098..29486256,2	K562	blood:
19	chr6:29481318..29483910-chr6:29486622..29489549,2	K562	blood:
20	chr6:29481318..29483910-chr6:29486622..29489549,2	K562	blood:
21	chr6:29483683..29485672-chr6:29497592..29500057,2	K562	blood:
22	chr6:29490586..29492205-chr6:29493882..29496471,2	K562	blood:
23	chr6:29498758..29502303-chr6:29502366..29506492,4	K562	blood:
24	chr6:29483683..29485672-chr6:29497592..29500057,2	K562	blood:
25	chr6:29498758..29502303-chr6:29502366..29506492,4	K562	blood:
26	chr6:29469820..29472263-chr6:29475289..29476878,2	MCF-7	breast:

(count:20 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-OR2H2-2	chr6:29497726-29497820	NONHSAT108526
2	lnc-OR2H2-2	chr6:29498829-29498945	NONHSAT108527
3	lnc-OR2H2-2	chr6:29497726-29497820	ENSG00000224582.1
4	lnc-OR2H2-2	chr6:29497726-29497820	ENSG00000224582.1
5	lnc-MAS1L-1	chr6:29446851-29447059	XLOC_005668
6	lnc-OR2H2-2	chr6:29498829-29498945	ENSG00000224582.1
7	lnc-OR2H2-2	chr6:29498829-29501345	NONHSAT108525
8	lnc-OR2H2-2	chr6:29497183-29497361	NONHSAT108525
9	lnc-OR2H2-2	chr6:29498829-29501345	NONHSAT108526
10	lnc-OR2H2-2	chr6:29498829-29501345	ENSG00000224582.1
11	lnc-OR2H2-2	chr6:29497959-29498322	NONHSAT108528
12	lnc-OR2H2-2	chr6:29497197-29497361	ENSG00000224582.1
13	lnc-OR2H2-2	chr6:29497183-29497361	NONHSAT108526
14	lnc-OR2H2-2	chr6:29499857-29499934	ENSG00000224582.1
15	lnc-OR2H2-2	chr6:29497726-29497820	NONHSAT108527
16	lnc-MAS1L-1	chr6:29444483-29444511	XLOC_005668
17	lnc-OR2H2-2	chr6:29498829-29499181	NONHSAT108528
18	lnc-OR2H2-2	chr6:29499857-29501345	NONHSAT108527
19	lnc-OR2H2-2	chr6:29497253-29497361	ENSG00000224582.1
20	lnc-OR2H2-2	chr6:29497183-29497361	NONHSAT108527

No data

Variant related genes	Relation type
LINC01015	TF binding region
MAS1L	TF binding region
MAS1LP1	TF binding region
UBDP1	TF binding region
ENSG00000229274	TF binding region
RPS17P1	TF binding region
LINC01015	CpG island
MAS1L	CpG island
MAS1LP1	CpG island
UBDP1	CpG island
ENSG00000229274	CpG island
RPS17P1	CpG island
ENSG00000204687	chromatin interactions
ENSG00000229281	chromatin interactions
NME4	miRNA target sites

Extended variants
information (count: 1916 )
Associated
traits (count: 108 )

Variant overlapped rSNPs/rCNVs (count:1916 , 50 per page) page: 1 2 3 4 5 6 7 ... 39

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs186804862	chr6:29439341-29439342	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs191272650	chr6:29439379-29439380	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs547192400	chr6:29439411-29439412	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs114765963	chr6:29439428-29439429	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs114987186	chr6:29442603-29442604	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs2746150	chr6:29442701-29442702	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
7	rs142971090	chr6:29442704-29442705	Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs555986322	chr6:29442786-29442787	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs369494866	chr6:29442843-29442844	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs555234492	chr6:29442888-29442889	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs373535422	chr6:29442896-29442897	Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs58211986	chr6:29442931-29442932	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs77454196	chr6:29442975-29442976	Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs190470752	chr6:29442979-29442980	Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs535408828	chr6:29443004-29443005	Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs553567505	chr6:29443005-29443006	Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs575231539	chr6:29443137-29443138	Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs546232518	chr6:29443166-29443167	Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs562838866	chr6:29443186-29443187	Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs147451970	chr6:29443194-29443195	Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs552435346	chr6:29443319-29443320	Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs182708630	chr6:29443370-29443371	Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs567943859	chr6:29443388-29443389	Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs527555039	chr6:29443422-29443423	Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs139907586	chr6:29443496-29443497	Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs370090948	chr6:29443500-29443501	Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs116045232	chr6:29445406-29445407	Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs535445614	chr6:29445445-29445446	Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs555372703	chr6:29445492-29445493	Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs7756110	chr6:29445495-29445496	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs541146970	chr6:29445496-29445497	Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs564091677	chr6:29445502-29445503	Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs577775569	chr6:29445536-29445537	Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs375971481	chr6:29445558-29445559	Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs543304986	chr6:29445609-29445610	Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs563596043	chr6:29445656-29445657	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs72500877	chr6:29445702-29445703	Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs373929741	chr6:29445749-29445750	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs559419919	chr6:29445785-29445786	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs143139397	chr6:29445820-29445821	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs554905684	chr6:29445843-29445844	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs187670927	chr6:29445863-29445864	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs369502437	chr6:29445999-29446000	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs570919076	chr6:29446000-29446001	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs192059006	chr6:29446018-29446019	Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs116034111	chr6:29446064-29446065	Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs991138	chr6:29446077-29446078	Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs569996334	chr6:29446155-29446156	Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs535770855	chr6:29446178-29446179	Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs555311405	chr6:29446198-29446199	Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:108)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Lung cancer	18438408	CNVD
Ewing''s sarcoma	17952124	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Gastric cancer	16891809	CNVD
Ovarian cancer	21781307	CNVD
Autism	21448237	CNVD
Cancer	20164919	CNVD
Melanoma	18172304	CNVD
Breast cancer	22844521	CNVD
HIV/AIDS	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21552322	CNVD
Immune disease	21076436	CNVD
Autoimmune disease	19135723	CNVD
Systemic lupus erythematosus	17953491	CNVD
Recurrent Infections	22737222	CNVD
Systemic lupus erythematosus	21904924	CNVD
Ependymoma	19289631	CNVD
Gestational infection	22844521	CNVD
Head circumference	22844521	CNVD
Infertility	22844521	CNVD
Recurrent birth weight diabetes	22844521	CNVD
Obesity	22844521	CNVD
Recurrent pregnancy loss	22844521	CNVD
Intellectual disability	21811512	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Nasopharyngeal cancer	22815911	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	21115979	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	17133270	CNVD
Autism	22495311	CNVD
Cancer	16790693	CNVD
Breast cancer	22032731	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21785460	CNVD
Retinoblastoma	16790693	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
T-cell lymphomas	19863542	CNVD
Urothelial carcinoma	18382360	CNVD
Cancer	21183584	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
Renal cell carcinoma	18765545	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Gastric cancer	17908304	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16397240	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	21364760	CNVD
Schizophrenia	19571809	CNVD
Schizophrenia	19571808	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Neuroblastoma	16790693	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
abnormal development	18461090	CNVD
Breast cancer	21509527	CNVD
Schizophrenia	23813976	CNVD
Melanoma	17363583	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:127 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:29442600-29443600	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
2	chr6:29442800-29443200	Enhancers	HMEC	breast
3	chr6:29445400-29446200	Enhancers	K562	blood
4	chr6:29450800-29451600	Enhancers	NH-A	brain
5	chr6:29451200-29452200	Enhancers	Liver	Liver
6	chr6:29452200-29457000	Weak transcription	Liver	Liver
7	chr6:29454000-29455600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
8	chr6:29454200-29454800	Enhancers	Primary hematopoietic stem cells	blood
9	chr6:29454200-29455000	Enhancers	Primary hematopoietic stem cells short term culture	blood
10	chr6:29454200-29455400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
11	chr6:29454400-29456000	Enhancers	K562	blood
12	chr6:29454800-29457800	Weak transcription	Primary hematopoietic stem cells	blood
13	chr6:29455000-29457200	Weak transcription	Primary hematopoietic stem cells short term culture	blood
14	chr6:29455400-29457200	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
15	chr6:29455600-29457200	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
16	chr6:29456000-29457800	Weak transcription	K562	blood
17	chr6:29457000-29457400	Enhancers	Liver	Liver
18	chr6:29457200-29458000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
19	chr6:29457200-29459400	Enhancers	Primary hematopoietic stem cells short term culture	blood
20	chr6:29457200-29461200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
21	chr6:29457800-29458600	Enhancers	Primary neutrophils fromperipheralblood	blood
22	chr6:29457800-29459800	Enhancers	Primary hematopoietic stem cells	blood
23	chr6:29457800-29459800	Enhancers	K562	blood
24	chr6:29458000-29459000	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
25	chr6:29459000-29459600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
26	chr6:29459000-29461200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
27	chr6:29459400-29462200	Weak transcription	Primary hematopoietic stem cells short term culture	blood
28	chr6:29459800-29460200	Weak transcription	Primary hematopoietic stem cells	blood
29	chr6:29459800-29461800	Weak transcription	K562	blood
30	chr6:29460200-29461000	Enhancers	Primary hematopoietic stem cells	blood
31	chr6:29461800-29462400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
32	chr6:29461800-29462600	Enhancers	K562	blood
33	chr6:29462200-29462400	Enhancers	Primary hematopoietic stem cells short term culture	blood
34	chr6:29464000-29464400	Enhancers	K562	blood
35	chr6:29468200-29468400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
36	chr6:29468400-29468600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
37	chr6:29468600-29496200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
38	chr6:29469800-29471400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
39	chr6:29469800-29471400	Enhancers	NH-A	brain
40	chr6:29470000-29470200	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
41	chr6:29470200-29470600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
42	chr6:29470200-29470600	Enhancers	NHEK	skin
43	chr6:29470200-29470800	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
44	chr6:29470200-29471200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
45	chr6:29470200-29471200	Enhancers	NHDF-Ad	bronchial
46	chr6:29470400-29471000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
47	chr6:29472800-29473200	Enhancers	HepG2	liver
48	chr6:29475200-29477800	Enhancers	GM12878-XiMat	blood
49	chr6:29475600-29475800	Enhancers	HSMMtube	muscle
50	chr6:29475800-29476000	Flanking Active TSS	HSMMtube	muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links